1188277-05-5
1188277-05-5
Chemical Structure
Flanvotumab
Synonym(s): IMC-20D7S
- CAS No.: 1188277-05-5
- Formula:N/A
- Molecular Weight:(145.5 kDa)
IUPAC Name: methyl 4-bromo-5-sulfamoylthiophene-2-carboxylate
SMILES: [Flanvotumab]
Biological Activity: Flanvotumab (IMC-20D7S) is a human monoclonal antibody targeting to tyrosinase-related protein (TYRP1), specifically expressed in melanocytes and melanoma cells. Flanvotumab acts function via natural killing-mediated antibody-dependent cell-mediated cytotoxicity (ADCC). Flanvotumab has potent anti-tumor activity and good tolerance[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Flanvotumab | ≥99.0% | Flanvotumab (IMC-20D7S) is a human monoclonal antibody targeting to tyrosinase-related protein (TYRP1), specifically expressed in melanocytes and melanoma cells. Flanvotumab acts function via natural killing-mediated antibody-dependent cell-mediated cytotoxicity (ADCC). Flanvotumab has potent anti-tumor activity and good tolerance. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
